RPRX/N fundamentals
ROYALTY PHARMA PLC revenue breakdown overview
ROYALTY PHARMA PLC revenue for the last year amounted to 58.40 B MXN, the most of which — 47.19 B MXN — came from its highest performing source at the moment, Biopharmaceutical Royalties, the year earlier bringing 39.99 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought ROYALTY PHARMA PLC 47.19 B MXN, and the year before that — 39.99 B MXN.
By source
2017
2018
2019
2020
2021
2022
2023
2024
0.00
12.00 B
24.00 B
36.00 B
48.00 B
Biopharmaceutical Royalties
Currency: MXN
2017
2018
2019
2020
2021
2022
2023
2024
Biopharmaceutical Royalties
42.29 B
47.02 B
43.64 B
39.99 B
47.19 B
By country
2017
2018
2019
2020
2021
2022
2023
2024
0.00
12.00 B
24.00 B
36.00 B
48.00 B
United States
Currency: MXN
2017
2018
2019
2020
2021
2022
2023
2024
United States
42.29 B
47.02 B
43.64 B
39.99 B
47.19 B